Long-term Outcomes of High-Risk HR-positive and HER2-negative Early Breast Cancer Patients from GEICAM Adjuvant Studies and El Álamo IV Registry
Breast Cancer Research and Treatment(2023)
Key words
High-risk,Early breast cancer,Hormone receptor (HR)-positive,HER2-negative
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined